Get the Stockscreener App
6.71
6.81%
-0.49
After Hours:
6.81
0.10
+1.49%
Aurora Cannabis Inc. stock is currently priced at $6.71, with a 24-hour trading volume of 4.27M.
It has seen a -6.81% decreased in the last 24 hours and a +62.08% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $7.24 pivot point. If it approaches the $6.56 support level, significant changes may occur.
Previous Close:
$7.20
Open:
$7
24h Volume:
4.27M
Market Cap:
$365.96M
Revenue:
$195.82M
Net Income/Loss:
$-88.78M
P/E Ratio:
-2.8386
EPS:
-2.3638
Net Cash Flow:
$-88.86M
1W Performance:
+2.68%
1M Performance:
+62.08%
6M Performance:
+57.47%
1Y Performance:
+18.97%
1D Range:
$6.71
$7.11
52W Range:
$2.84
$11.50
Aurora Cannabis Inc. Stock (ACB) Company Profile
Name
Aurora Cannabis Inc.
Sector
Phone
-
Address
10355 Jasper Avenue, Suite 500, Edmonton, AB
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-21-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-24-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jun-06-22 | Upgrade | Stifel | Sell → Hold |
| Sep-28-21 | Upgrade | MKM Partners | Sell → Neutral |
| Sep-03-21 | Upgrade | Jefferies | Underperform → Hold |
| May-14-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-14-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| May-11-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-28-21 | Resumed | BofA Securities | Neutral |
| Feb-12-21 | Downgrade | Desjardins | Hold → Sell |
| Feb-12-21 | Downgrade | MKM Partners | Neutral → Sell |
| Feb-12-21 | Downgrade | Needham | Hold → Underperform |
| Dec-18-20 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-27-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-24-20 | Upgrade | Stifel | Sell → Hold |
| May-22-20 | Downgrade | Jefferies | Hold → Underperform |
| May-15-20 | Upgrade | Piper Sandler | Underweight → Neutral |
| Feb-27-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Feb-25-20 | Initiated | Needham | Hold |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-14-20 | Upgrade | MKM Partners | Sell → Neutral |
| Feb-07-20 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jan-10-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-10-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-23-19 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-24-19 | Initiated | CIBC | Neutral |
View All
Aurora Cannabis Inc. Stock (ACB) Latest News
Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
Zacks Investment Research
Aurora Cannabis Inc. (ACB) Suffers a Larger Drop Than the General Market: Key Insights
Zacks Investment Research
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Marijuana Stocks Got Burnt Today
The Motley Fool
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?
Benzinga
Aurora Cannabis Inc. Stock (ACB) Financials Data
Aurora Cannabis Inc. (ACB) Revenue 2024
ACB reported a revenue (TTM) of $195.82 million for the quarter ending December 31, 2023, a +18.76% rise year-over-year.
Aurora Cannabis Inc. (ACB) Net Income 2024
ACB net income (TTM) was -$88.78 million for the quarter ending December 31, 2023, a +93.57% increase year-over-year.
Aurora Cannabis Inc. (ACB) Cash Flow 2024
ACB recorded a free cash flow (TTM) of -$88.86 million for the quarter ending December 31, 2023, a +25.56% increase year-over-year.
Aurora Cannabis Inc. (ACB) Earnings per Share 2024
ACB earnings per share (TTM) was -$2.5089 for the quarter ending December 31, 2023, a +95.94% growth year-over-year.
About Aurora Cannabis Inc.
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
2.03%
4.37%
Cap:
|
Volume (24h):